ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.43
0.77%
US Tech 100
18,360.40
1.02%
S&P 500
5,314.43
0.44%
US Dollar vs CAD
1.37225
0.33%
Bitcoin
70,969.02
0.49%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE
  6. Genuit Group Plc (GEN)

  7. Genuit Group Plc (GEN) News

GEN

Genuit (GEN)

Genuit Group Plc
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:GEN
DateTimeSourceHeadlineSymbolCompany
05/28/20248:14AMRNS Regulatory NewsGenuit Group PLC Result of AGMLSE:GENGenuit Group Plc
05/28/20244:44AMAlliance NewsAlliance NewsGenuit revenue falls due to weak housebuilding and wet weather in UKLSE:GENGenuit Group Plc
05/28/20241:00AMRNS Regulatory NewsGenuit Group PLC Trading UpdateLSE:GENGenuit Group Plc
05/14/20242:00AMPR Newswire (US)Deepfakes, AI-Manipulated Audio, and Hijacked Social Media Surge in 2024LSE:GENGenuit Group Plc
05/02/202410:57AMRNS Regulatory NewsGenuit Group PLC Block listing Interim ReviewLSE:GENGenuit Group Plc
04/24/20244:39AMRNS Regulatory NewsGenuit Group PLC Notice of AGMLSE:GENGenuit Group Plc
04/10/202410:24AMRNS Regulatory NewsGenuit Group PLC Director/PDMR ShareholdingLSE:GENGenuit Group Plc
04/10/202410:17AMRNS Regulatory NewsGenuit Group PLC Director/PDMR ShareholdingLSE:GENGenuit Group Plc
04/09/202410:28AMRNS Regulatory NewsGenuit Group PLC Director DeclarationLSE:GENGenuit Group Plc
04/02/20249:56AMRNS Regulatory NewsGenuit Group PLC Director/PDMR ShareholdingLSE:GENGenuit Group Plc
03/20/202410:27AMRNS Regulatory NewsGenuit Group PLC Director/PDMR ShareholdingLSE:GENGenuit Group Plc
03/12/20245:40AMAlliance NewsAlliance NewsGenuit revenue drops on lower divisional sales but profit surgesLSE:GENGenuit Group Plc
03/12/20242:09AMAlliance NewsAlliance News*Genuit says 2024 trading has started in line w/ expectations, despite market uncertaintyLSE:GENGenuit Group Plc
03/12/20242:09AMAlliance NewsAlliance News*Genuit declares total dividend per share of 12.4p vs 12.3p YoYLSE:GENGenuit Group Plc
03/12/20242:07AMAlliance NewsAlliance News*Genuit 2023 pretax profit GBP48.4m vs GBP45.4m YoYLSE:GENGenuit Group Plc
03/12/20242:00AMRNS Regulatory NewsGenuit Group PLC Final ResultsLSE:GENGenuit Group Plc
03/01/20242:30AMRNS Regulatory NewsGenuit Group PLC Director DeclarationLSE:GENGenuit Group Plc
02/19/20243:00AMRNS Regulatory NewsGenuit Group PLC Notice of Results and Investor PresentationLSE:GENGenuit Group Plc
01/23/20249:49AMUK RegulatoryGenuit Group PLC Holding(s) in CompanyLSE:GENGenuit Group Plc
01/23/20245:24AMUK RegulatoryGenmab A/S Genmab Announces Net Sales Of Darzalex(R) (daratumumab) For 2023LSE:GENGenuit Group Plc
01/22/20245:40PMUK RegulatoryGenmab A/S Genmab Announces Decision In Arbitration Appeal Under License Agreement With JanssenLSE:GENGenuit Group Plc
01/09/20245:45AMUK RegulatoryGenmab A/S Tivdak(R) (tisotumab vedotin-tftv) Supplemental Biologics License Application Accepted For Priority Review By U.S. Food And Drug Administration For Patients With Recurrent Or Metastatic Cervical CancerLSE:GENGenuit Group Plc
01/02/202411:55PMUK RegulatoryGenmab A/S Transactions With Shares And Linked Securities In Genmab A/S Made By Managerial Employees And Their Closely Associated PersonsLSE:GENGenuit Group Plc
01/02/20248:52AMUK RegulatoryGenmab A/S Genmab To Present At The 42nd Annual J.P. Morgan Healthcare ConferenceLSE:GENGenuit Group Plc
12/12/20236:00AMUK RegulatoryGenmab A/S Genmab To Hold 2023 R&D Update And Ash Data Review MeetingLSE:GENGenuit Group Plc
12/09/202311:00AMUK RegulatoryGenmab A/S New Pivotal Data For Bispecific Antibody Epcoritamab (DuoBody(R) Cd3xcd20) Demonstrates High Overall And Complete Responses In Patients With Hard-To-Treat Relapsed/Refractory Follicular Lymphoma (FL)LSE:GENGenuit Group Plc
12/05/20234:26PMUK RegulatoryGenmab A/S Capital Increase In Genmab As A Result Of Employee Warrant ExerciseLSE:GENGenuit Group Plc
11/27/20236:00AMUK RegulatoryGenmab A/S Genmab Announces Positive Regulatory Updates For Epcoritamab (EPKINLY(R)/Tepkinly(R)) For The Treatment Of Relapsed/Refractory Follicular LymphomaLSE:GENGenuit Group Plc
11/22/20231:00AMUK RegulatoryGenuit Group PLC Strategy Progress Update NotificationLSE:GENGenuit Group Plc
11/21/20233:45PMUK RegulatoryGenmab A/S Transactions With Shares And Linked Securities In Genmab A/S Made By Managerial Employees And Their Closely Associated PersonsLSE:GENGenuit Group Plc
 Showing the most relevant articles for your search:LSE:GEN

Your Recent History

DOWI
DJCINGP
DJ Commodity Index Natur...
NASDAQI
B35GI
OMX Baltic Real Estate GI
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved